Charles Piller, an investigative journalist for Science Magazine and author of "Doctored," exposes the dark side of Alzheimer's research. He reveals how fraudulent studies, like one that cemented the amyloid hypothesis, misled the field for decades. Piller discusses NIH funding incentives encouraging flawed research and the heroic roles of whistleblowers uncovering manipulation. He underscores the urgent need for transparency while highlighting promising new avenues in treatment, such as viral research and GLP-1 inhibitors, instilling hope for patients and families alike.
51:34
forum Ask episode
web_stories AI Snips
view_agenda Chapters
menu_book Books
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
Team Science and Red Flags
Modern biomedical science is a team sport, requiring collaboration and open communication.
Unconventional PIs who limit others' involvement or handle figures alone raise red flags.
insights INSIGHT
PubPeer's Role
PubPeer allows anonymous questioning of published research, particularly image veracity.
While controversial, it addresses journals' insufficient image scrutiny, highlighting a critical gap in scientific literature.
question_answer ANECDOTE
Images as Data in Alzheimer's
Micrographs of brain tissue and Western blots are common image data in Alzheimer's research.
Manipulating these images can falsely portray experimental success, particularly regarding amyloid protein.
Get the Snipd Podcast app to discover more snips from this episode
In this episode of Inquiring Minds, host Indre Viskontas speaks with investigative journalist Charles Piller about his explosive new book, Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer's. Piller unearths the troubling reality behind decades of Alzheimer's research, exposing how fraudulent data, unchecked ambition, and institutional failures have shaped the field—and wasted billions of dollars—while millions of patients and families await real solutions.
Piller shares:
How a single falsified study published in Nature helped cement the amyloid hypothesis as the dominant theory of Alzheimer’s, despite mounting evidence against it.
The role of NIH funding incentives in steering researchers toward confirming flawed findings instead of exploring alternative approaches.
The rise of scientific sleuths and whistleblowers like Matthew Schrag, who uncovered image manipulation in key Alzheimer’s studies.
The institutional failures of major scientific journals, regulatory agencies, and funding bodies that allowed bad science to shape drug development for decades.
Why Alzheimer’s patients and their families are still waiting for effective treatments, and what promising new directions could finally lead to breakthroughs.
Despite the troubling revelations, Piller also highlights reasons for optimism, including emerging research into alternative causes of Alzheimer’s, such as viral infections and neuroinflammation, and promising clinical trials involving GLP-1 inhibitors.
Listen in for a gripping and eye-opening discussion about how scientific fraud derailed progress in Alzheimer’s research—and how we can chart a new path forward. Doctored is available now at booksellers everywhere.
Inquiring Minds 
